Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients

NCT ID: NCT06913504

Last Updated: 2025-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

54 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-20

Study Completion Date

2026-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparing Blue Light Filter feature and Blue Blocking Lenses for Dry Eye Patients Prolonged screen time can exacerbate dry eye symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Two solutions, blue light filter software and blue blocking lenses, aim to reduce eye strain. Blue light filter software adjusts screen color temperatures, reducing blue light emission. Blue blocking lenses provide a physical barrier, blocking blue light from reaching the eyes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndromes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blue cut filter

Group Type EXPERIMENTAL

Blue cut filter

Intervention Type DIAGNOSTIC_TEST

Group 1 will be prescribe with blue cut filter feature

blue cut glasses

Group Type EXPERIMENTAL

blue cut glasses

Intervention Type DIAGNOSTIC_TEST

Group 2 will be prescribed with blue cut glasses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blue cut filter

Group 1 will be prescribe with blue cut filter feature

Intervention Type DIAGNOSTIC_TEST

blue cut glasses

Group 2 will be prescribed with blue cut glasses

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 12-34
* Spend at least 4 hours per day on digital devices.
* Experience dry eye symptoms.
* Willing to participate in the study and provide informed consent.

Exclusion Criteria

* Pre-existing eye conditions (e.g., cataracts, glaucoma).
* Wear contact lenses.
* Have undergone eye surgery.
* Are pregnant or breastfeeding.
Minimum Eligible Age

12 Years

Maximum Eligible Age

34 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Superior University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muhammad Naveed Babur

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Khursheed baigam eye hospital raiwind road manga mandi

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSRSW/Batch-Fall23/804

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.